Literature DB >> 24797826

Wnt-responsive cancer stem cells are located close to distorted blood vessels and not in hypoxic regions in a p53-null mouse model of human breast cancer.

Tegy J Vadakkan1, John D Landua2, Wen Bu2, Wei Wei2, Fuhai Li2, Stephen T C Wong2, Mary E Dickinson2, Jeffrey M Rosen2, Michael T Lewis2, Mei Zhang1.   

Abstract

Cancer stem cells (CSCs, or tumor-initiating cells) may be responsible for tumor formation in many types of cancer, including breast cancer. Using high-resolution imaging techniques, we analyzed the relationship between a Wnt-responsive, CSC-enriched population and the tumor vasculature using p53-null mouse mammary tumors transduced with a lentiviral Wnt signaling reporter. Consistent with their localization in the normal mammary gland, Wnt-responsive cells in tumors were enriched in the basal/myoepithelial population and generally located in close proximity to blood vessels. The Wnt-responsive CSCs did not colocalize with the hypoxia-inducible factor 1α-positive cells in these p53-null basal-like tumors. Average vessel diameter and vessel tortuosity were increased in p53-null mouse tumors, as well as in a human tumor xenograft as compared with the normal mammary gland. The combined strategy of monitoring the fluorescently labeled CSCs and vasculature using high-resolution imaging techniques provides a unique opportunity to study the CSC and its surrounding vasculature. ©AlphaMed Press.

Entities:  

Keywords:  Cancer stem cells; In vivo optical imaging; Microvasculature; Signal transduction; Stem cell microenvironment; p53

Mesh:

Substances:

Year:  2014        PMID: 24797826      PMCID: PMC4073819          DOI: 10.5966/sctm.2013-0088

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  51 in total

1.  A hybrid 3D watershed algorithm incorporating gradient cues and object models for automatic segmentation of nuclei in confocal image stacks.

Authors:  Gang Lin; Umesh Adiga; Kathy Olson; John F Guzowski; Carol A Barnes; Badrinath Roysam
Journal:  Cytometry A       Date:  2003-11       Impact factor: 4.355

2.  Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice.

Authors:  K B DEOME; L J FAULKIN; H A BERN; P B BLAIR
Journal:  Cancer Res       Date:  1959-06       Impact factor: 12.701

Review 3.  Self-renewal and cancer of the gut: two sides of a coin.

Authors:  Freddy Radtke; Hans Clevers
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

4.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.

Authors:  D Bonnet; J E Dick
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

5.  Targeting androgen receptor in estrogen receptor-negative breast cancer.

Authors:  Min Ni; Yiwen Chen; Elgene Lim; Hallie Wimberly; Shannon T Bailey; Yuuki Imai; David L Rimm; X Shirley Liu; Myles Brown
Journal:  Cancer Cell       Date:  2011-07-12       Impact factor: 31.743

6.  In vivo measurements of "apparent viscosity" and microvessel hematocrit in the mesentery of the cat.

Authors:  H H Lipowsky; S Usami; S Chien
Journal:  Microvasc Res       Date:  1980-05       Impact factor: 3.514

7.  Role of tumor vascular architecture in nutrient and drug delivery: an invasion percolation-based network model.

Authors:  J W Baish; Y Gazit; D A Berk; M Nozue; L T Baxter; R K Jain
Journal:  Microvasc Res       Date:  1996-05       Impact factor: 3.514

8.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Authors:  T Lapidot; C Sirard; J Vormoor; B Murdoch; T Hoang; J Caceres-Cortes; M Minden; B Paterson; M A Caligiuri; J E Dick
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

9.  Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions.

Authors:  J R Less; T C Skalak; E M Sevick; R K Jain
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

10.  Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature.

Authors:  M W Dewhirst; C Y Tso; R Oliver; C S Gustafson; T W Secomb; J F Gross
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-07       Impact factor: 7.038

View more
  4 in total

Review 1.  Identifying and targeting tumor-initiating cells in the treatment of breast cancer.

Authors:  Wei Wei; Michael T Lewis
Journal:  Endocr Relat Cancer       Date:  2015-04-15       Impact factor: 5.678

Review 2.  Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.

Authors:  Yoav Shetzer; Alina Molchadsky; Varda Rotter
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

Review 3.  Roles of Wnt Target Genes in the Journey of Cancer Stem Cells.

Authors:  Jee-Heun Kim; So-Yeon Park; Youngsoo Jun; Ji-Young Kim; Jeong-Seok Nam
Journal:  Int J Mol Sci       Date:  2017-07-25       Impact factor: 5.923

Review 4.  3D modeling of cancer stem cell niche.

Authors:  Jun He; Li Xiong; Qinglong Li; Liangwu Lin; Xiongying Miao; Shichao Yan; Zhangyong Hong; Leping Yang; Yu Wen; Xiyun Deng
Journal:  Oncotarget       Date:  2017-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.